PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,361 stories, page 738 of 773

Advanced search
🇺🇰Researchroyalfree.nhs.ukTier 2 · Direct publisher

Changes to our patient and visitor car parking charges - Royal Free London

Royal Free London NHS Foundation TrustOriginal source
🇺🇰Researchroyalfree.nhs.ukTier 2 · Direct publisher

Celebrating International Nurses Day - Royal Free London

Royal Free London NHS Foundation TrustOriginal source
🇳🇱Researchradboudumc.nlTier 2 · Direct publisher

Subscribe and/or submit

Radboudumc (Nijmegen)Original source
🇳🇱Researchradboudumc.nlTier 2 · Direct publisher

Blog: The cost of knowledge - What do we pay to publish our research, and is it always worth the price?

Radboudumc (Nijmegen)Original source
🇺🇸Industryprotagonist-inc.comTier 1 · Company source

Protagonist CEO Dinesh V. Patel and Chief Discovery Officer Ashok Bhandari Speak with BiotechTV

Protagonist TherapeuticsOriginal source
🇺🇸Industryprotagonist-inc.comTier 1 · Company source

Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113), a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor

Protagonist TherapeuticsOriginal source
🇺🇸Industryprotagonist-inc.comTier 1 · Company source

Polycythemia Vera: Mechanism of Disease

Protagonist TherapeuticsOriginal source
🇺🇸Industryprotagonist-inc.comTier 1 · Company source

Cancer Moonshot: How We’re Helping Patients

Protagonist TherapeuticsOriginal source
🇺🇸Industryprotagonist-inc.comTier 1 · Company source

BioSpace covers ICOTYDE™ FDA Approval

Protagonist TherapeuticsOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

September 22, 2025 Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

Profluent | Reprogramming CRISPR Systems for Customized Genome Editing

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

January 7, 2025 Profluent Demonstrates AI Can Engineer Protein-DNA Interactions Without Iterative Laboratory Screening Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

April 16, 2025 Profluent Introduces ProGen3, Demonstrating Scaling Laws for Foundation Models in Writing Biology Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

Profluent | Profluent Partners With BioMarin to Design Novel Medicines Using AI

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

December 9, 2025 Profluent Bio Announces Strategic Collaboration with Ensoma to Develop AI-Designed Base Editors for In Vivo Hematopoietic Stem Cell Therapies Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

Profluent | Profluent Announces Strategic Partnership with Eli Lilly to Develop AI-Designed Recombinases for Genetic Medicine

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

July 30, 2025 Profluent Announces Publication of Generative AI Research in Nature with New Results for OpenCRISPR-1 Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

October 6, 2025 Profluent Announces Multi-Year Collaboration with Corteva to Accelerate Sustainable, AI-Powered Crop Innovation Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

November 17, 2025 Profluent and RSRT Partner to Tackle Rett Syndrome with AI-Designed Custom Genomic Medicines Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

October 24, 2025 Profluent and Corteva Partner to Apply AI-Designed Proteins In Agriculture Press

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

- YouTube

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

Profluent | Lilly, Profluent Ink Deal on AI Drugs Worth Up to $2.25 Billion

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

November 19, 2025 Jeff Bezos Is Backing An AI Startup Aiming To Make Proteins Programmable Press

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

October 21, 2025 Integrated DNA Technologies and Profluent Collaborate to Unlock New Frontier of AI-driven Protein Design Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

August 5, 2024 Generating Proteins with Atomic-level Control Blog

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

July 9, 2026 GEMMABio Awarded ARPA-H Funding to Pursue Innovative Base-editing Strategy for Rare Liver Diseases Announcement

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

April 28, 2026 Eli Lilly enlists AI startup for next-generation gene editors Press

ProfluentOriginal source
🇺🇸Industryprofluent.bioTier 1 · Company source

July 9, 2026 ARPA-H awards to advance personalized curative medicines for rare genetic diseases Announcement

ProfluentOriginal source
🇺🇸Industryprecisionformedicine.comTier 1 · Company source

Precision Medicine Group Launches Institute@Precision, a Collaborative Forum for Biopharma Innovation

Precision for MedicineOriginal source
🇺🇸Industryprecisionformedicine.comTier 1 · Company source

Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office

Precision for MedicineOriginal source
🇺🇸Industryprecisionformedicine.comTier 1 · Company source

Precision for Medicine Broadens Global Footprint with Singapore Office Opening

Precision for MedicineOriginal source
🇺🇸Industryprecisionformedicine.comTier 1 · Company source

Laboratory Operations and Technology Innovator Chris Clendening Joins Precision for Medicine to Lead Specialty Labs

Precision for MedicineOriginal source
🇺🇸Industryprecisionformedicine.comTier 1 · Company source

FDA Veteran Paz Vellanki, MD, PhD, Joins Precision for Medicine, Forming a Trio of Former Regulatory Leaders

Precision for MedicineOriginal source
🇺🇸Industryprecisionformedicine.comTier 1 · Company source

Amanda Owens Joins Precision for Medicine To Expand Access to Fit-for-Purpose Biospecimens for Advanced Research

Precision for MedicineOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide strengthens financing structure through expansion of existing credit facility

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide publishes invitation to the annual General Meeting 2026

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide Group AG takes note of market rumors and speculation

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide delivers strong revenue growth and marked improvement in profitability

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide announces results of the annual General Meeting 2026

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet Growing Demand for Peptide Supply in Metabolic Therapies

PolyPeptide GroupOriginal source
🌍Investorpolypeptide.comTier 2 · Direct publisher

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

PolyPeptide GroupOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

이용안내

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

장례식장소개 | 부산대학교병원-메인

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

병리검사 슬라이드 발급

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

의료영상사본 발급

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

의무기록사본 발급

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

오시는 길

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

층별안내도

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

로그인 | 부산대학교병원-메인

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

병문안 안내 | 부산대학교병원-메인

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

간호간병통합서비스 안내

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

입원생활안내[영상] | 부산대학교병원-메인

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

진료안내 | 부산대학교병원-메인

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

보험별 진료절차 | 부산대학교병원-메인

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

심층진찰 시범사업

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

하이패스 서비스안내 | 부산대학교병원-메인

Pusan National University HospitalOriginal source
🇰🇷Researchpnuh.or.krTier 2 · Direct publisher

의료전달체계

Pusan National University HospitalOriginal source